Skip to search formSkip to main contentSkip to account menu

tepoxalin

Known as: 5-(4-chlorophenyl)-N-hydroxy-1-(4-methoxyphenyl)-N-methyl-1H-pyrazole-3-propanamide 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Anti-Inflammatory Agents, Non-SteroidalImmunosuppressive AgentsPyrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Tepoxalin no longer available commercially.
2011
2011
Effect of tepoxalin on fecal cortisol concentration in Rabbits after ovariohysterectomy.
Determination of the analgesic efficacy of tepoxalin after ovariohysterectomy based on assessment of fecal cortisol concentration… 
2011
2011
EVALUATIONS OF THE METABOLIC PATTERN OF TEPOXALIN AFTER SINGLE ORAL ADMINISTRATION IN THE HORSE
2010
2010
Pharmacokinetics of tepoxalin and its major metabolite RWJ-20142 after oral administration in fasting/fed horses: preliminary evaluations
2010
2010
CAN TEPOXALIN BE A SUITABLE NSAID IN THE HORSE? A PK/PD STUDY
2010
2010
PHARMACOKINETICS OF TEPOXALIN AND ITS MAJOR METABOLITA RWJ-20142 AFTER ORAL ADMINISTRATION IN FASTING7FED HORSES: PRELIMINARY STUDY
2009
2009
Effects of the association of tepoxalin and enalapril on the renal function among dogs.
2009
2009
Effects of oral administration of tepoxalin (Zubrin®) on hemostasis and renal function in healthy dogs.
1995
1995
TEPOXALIN, A NOVEL IMMUNOMODULATORY COMPOUND, SYNERGIZES WITH CSA IN SUPPRESSION OF GRAFT‐VERSUS‐HOST REACTION AND ALLOGENEIC SKIN GRAFT REJECTION
Tepoxalin, a dual 5-lipoxygenase and cyclooxygenase inhibitor with nonsteroidal antiinflammatory effects, has recently been shown… 
1991
1991
Opthalmic aqueous fine emulsion of tepoxalin
PURPOSE: To obtain an ophthalmic anti-inflammatory agent composition suitable for local administration and thermodynamically…